1. T-OP 
  2. Network

Network

Beneficiaries

1. Ludwig-Maximilians-Universität, München
2. Danmarks Tekniske Universitet, Copenhagen
3. Amsterdam University Medical Centers, Amsterdam
4. Institut National de la Santé et de la Recherche Médicale, Tours
5. Paul-Ehrlich-Institut, Langen
6. Region Hovedstaden, University Hospital Herlev, Copenhagen
7. Universität Basel
8. Roche Glycart AG, Roche Innovation Center Zurich
9. Instil Bio Inc, Manchester
10. Université Paris-Saclay
11. Miltenyi Biotec BV & Co KG, Bergisch Gladbach
12. Hadassah Medical Organization, Jerusalem

Asscociated Partners

13. Université de Tours
14. Intelligent Omics Ltd, Nottingham
15. University of Manchester
16. Institut Gustave Roussy, Paris
17. University of Copenhagen

Sebastian Kobold

Coordinator Professor and Deputy Director of the Division of Clinical Pharmacology Ludwig-Maximilians-Universität Division of Clinical Pharmacology

 Lindwurmstraße 2a
D- 80337 München  Germany
+49 (0) 89 440057325
http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Klinische-Pharmakologie/de/index.html

Michael von Bergwelt

Director Department of Medicine III, University Hospital, LMU Munich Spokesperson German Cancer Consortium Munich-LMU Ludwig-Maximilians-Universität Medizinische Klinik und Poliklinik III Klinikum der Universität München

 Marchioninistraße 15
D-81377 Munich Germany
+49 (0) 89 440075551
http://www.klinikum.uni-muenchen.de/Medizinische-Klinik-und-Poliklinik-III/de/team/direktor/index.html

Sebastian Theurich

Professor for Cancer- and Immunometabolism, Attending Physician, Lead of Myeoma Program Ludwig-Maximilians-Universität Gene Center Munich

Feodor-Lynen-Straße 25 and Department of Medicine III, LMU University Hospital
D-81377 Munich Germany
+49 (0) 89 2180 76878
https://www.genzentrum.uni-muenchen.de/research-groups/theurich/group-members_new/theurich-sebastian/index.html

Sine Reker Hadrup

Professor Danmarks Tekniske Universitet Department of Health Technology Kemitorvet

Building 204, room 154
2800 Kgs. Lyngby Denmark
+45 (0) 35 886290
https://www.healthtech.dtu.dk/english

Tanja D. de Gruijl

Professor Translational Tumor Immunology and Head of the Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers Dept. Medical Oncology Amsterdam UMC

VUmc, CCA 2.44 DE BOELELAAN 1117
1081 HV Amsterdam Post  Netherlands
+31 (0) 20 4444063
https://research.vumc.nl/en/persons/tanja-de-gruijl

Christophe Paget

Senior Researcher at INSERM - UMR1100 Institut National de la Santé et de la Recherche Médicale

10 boulevard Tonnellé
37000  Tours France
+33 (0)247366068
https://cepr.inserm.univ-tours.fr/english-version

Christian Buchholz

Head of Molecular Biotechnology and Gene Therapy Paul-Ehrlich-Institut

Paul-Ehrlich-Str. 51-59
63225 Langen Germany
0049 6103 77 0
https://www.pei.de/DE/forschung/forschungsgruppen/praesident/molekulare-biotechnologie-gentherapie-node.html

Jessica Hartmann

Senior Research Associate and Regulatory Assessor Paul-Ehrlich-Institut Division of Medical Biotechnology

Paul-Ehrlich-Str. 51-59
D-63225 Langen  Germany
+49 (0) 6103774026
www.pei.de

Per Thor Straten

Director of Center for Cancer Immunotherapy Region Hovedstaden, University Hospital Herlev Center for Cancer Immunotherapy

Herlev Ringvej 75
DK-2730 Herlev  Denmark
+45 (0) 38 68 93 39
https://www.herlevhospital.dk/ccit-denmark/Sider/default.aspx

Alfred Zippelius

Head Cancer Immunology Universität Basel Department of Biomedicine (DBM)

Hebelstrasse 20
CH-4031Basel Switzerland
+41 (0)61 265 50 74
https://biomedizin.unibas.ch/en/research/research-groups/zippelius-rochlitz-lab/

Heinz Läubli

Research Group Leader of Cancer Immunotherapy Universität Basel Department of Biomedicine (DBM)

Hebelstrasse 20
CH-4031Basel Switzerland
+41 (0)61 265 23 55
https://biomedizin.unibas.ch/en/research/research-groups/laeubli-lab/

Christian Klein

Department Head Cancer Immunotherapy Discovery 3 & Site Head Roche Innovation Center Zurich, Roche Pharma Research & Early Development Roche Glycart AG, Roche Innovation Center Zurich

Wagistrasse 10
CH-8952 Schlieren Switzerland
+41 (0) 43 215 1628
www.roche.com

Robert Hawkins

Chief Strategy Advisor Instil Bio Inc

48 Grafton Street
Manchester M13 9XX UK
+44 7720708245
https://instilbio.com/about/

Laurence Zitvogel

Professor of Immunology at UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay

114, rue Édouard-Vaillant
F- 94805 Villejuif-Cedex France
+33 (0)1 42 11 42 11
https://www.universite-paris-saclay.fr/en

Jörg Mittelstät

Group Leader - R&D Reagents CAR technology research and translation - Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach Germany
+49 (0) 02204 8306-0
https://www.miltenyibiotec.com/DE-en/?countryRedirected=1

Sonja Schallenberg

Team Coordinator clinical T cell processing development R&D Immunotherapy - Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68
51429  Bergisch Gladbach Germany
02204 8306-0
https://www.miltenyibiotec.com/DE-en/?countryRedirected=1

Michal Lotem

Head of Center for Melanoma and Cancer Immunotherapy Sharett Institute Hadassah Medical Organization, HMO

POB12 000 Jerusalem Israel
+972-2-677-6781
http://www.hadassah-med.com/

Graham Ball

CSO Intelligent OMICS Ltd

C BioCity 1 Pennyfoot Street
Nottingham NG1 1GF UK
+44 (0)115 848 8308
https://www.intellomx.com/

David Andreu Sanz

ESR1, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich

Lindwurmstr. 2
80337  Munich Germany
Division of Clinical Pharmacology

Keerthana Ramanathan

ESR2, Reker's Lab, Danmarks Tekniske Universitet Department of Health Technology Kemitorvet

Building 204, room 154
2800 Kgs. Lyngby Denmark
Department of Health Technology Kemitorvet

Beatriz Costa

ESR 3, de Gruijl's Lab, Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers, Dept. Medical Oncology Amsterdam UMC

VUmc, CCA 2.48 DE BOELELAAN 1117
081 HV Amsterdam Post Netherlands

Fabian Richter

ESR4, Apetoh's Lab, Institut National de la Santé et de la Recherche Médicale INSERM U1100

10 boulevard Tonnellé
37000 Tours France
CEPR INSERM UMR 1100

Mar Guaza-Lasheras

ESR 5, Buchholz's Group, Paul-Ehrlich-Institut Division of Medical Biotechnology

Paul-Ehrlich-Str. 51-59
63225  Langen Germany
PEI

Annina Kurzay

ESR 6, thor Straten's Lab, Center for Cancer Immunotherapy, Region Hovedstaden, University Hospital Herlev

Herlev Ringvej 75
2730 Herlev Denmark
CCIT

Johanna Nimmerfroh

ESR 7, Zippelius and Läubli's Lab, Cancer Immunology, Cancer Immunotherapy, Department of Biomedicine (DBM), Universität Basel

Hebelstrasse 20
4031 Basel Switzerland 
Department of Biomedicine

Emanuele Carlini

ESR 8, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich

Lindwurmstr. 2
80337 Munich Germany
Division of Clinical Pharmacology
Urheberschaft ungeklärt

Dominic Schwarz

ESR 9, Klein's Lab, Department Cancer Immunotherapy Discovery 3, Roche Pharma Research & Early Development, Roche Glycart AG, Roche Innovation Center Zurich

Wagistrasse 10
8952  Schlieren Switzerland
Roche

Catarina Guerra

ESR 10, Hawkin's Lab, InstilBio Inc

48 Grafton Street
Manchester M13 9XX UK
IntilBio

Laura Marcos Kovandzic

ESR 11, Zitvogel's Lab, UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay

114, rue Édouard-Vaillant
94805 Villejuif-Cedex   Paris France
Université Paris-Saclay

Adriano Carboniero

ESR 12, Theurich's Lab, Gene Center Munich, Ludwig-Maximilians-Universität Munich

Feodor-Lynen-Straße 25 and Department of Medicine III, LMU University Hospital
81377 Munich Germany
Gene Center
Urheberschaft ungeklärt

Valeria Durante

ESR 13, Mittelstätt and Schallenberg's Group, R&D Reagents CAR technology research and translation, Team clinical T cell processing development Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach Germany
Miltenyi Biotec

Thy Luu

ESR 14, thor Straten's Lab, Center for Cancer Immunotherapy, Region Hovedstaden, University Hospital Herlev

Herlev Ringvej 75
2730 Herlev Denmark
CCIT
Urheberschaft ungeklärt

Imke Reith

ESR 15, Lotem's Lab, Center for Melanoma and Cancer Immunotherapy Sharett Institute Hadassah Medical Organization, HMO

POB12 000 Jerusalem Israel
RFHMO
  • 12 beneficiaries
  • 5 associated partners
  • 12 academic partners
  • 4 industrial partners
  • 1 public authority
  • 7 countries